obesity drug news today glp-1 2025 sep 30 Agonists Weight Loss Drugs Market Report, 2025-2030 Alarming rise in weight loss
Description
GLP-1 drugs Bariatric surgery remains the most effective option for long-term weight loss in appropriately selected patients
What does the FDA say about GLP-1s
Knudsen was not the only one interested in obesity at Novo Nordisk
About this article Cite this article Gilbert, S.J., Vazquez, S.R., Gouripeddi, R
At PSG, weve seen off-label GLP-1 spend reach as high as 50% among payers without tight utilization controls
